Eubiotics Market Report Covers Future Trends with Research 2021 to 2028 | BASF SE, Novus International, Lallemand Inc., Cargill Inc.,

The global eubiotics market size is expected to reach USD 10.89 Billion in 2028 and register a CAGR of 8.0% over the forecast period, according to latest analysis by Emergen Research.

The Eubiotics Market is an emerging market that is rapidly gaining attention due to its various benefits. Eubiotics are a type of feed additives that help to improve animal health and performance. They are mainly used in the livestock industry to improve the gut health of animals, which in turn enhances their immunity and reduces the risk of diseases.

One of the major drivers of the eubiotics market is the increasing demand for meat and animal-based products worldwide. The growing population and changing dietary habits have led to an increase in the demand for meat, dairy, and other animal-based products. This has resulted in an increased need for eubiotics in the livestock industry to improve animal health and productivity. Additionally, the rising awareness among consumers about the health benefits of eubiotics is expected to drive market growth.

However, the eubiotics market also faces some restraints. One of the major challenges faced by the market is the stringent regulations imposed by various government bodies on the use of eubiotics. The regulations are aimed at ensuring the safety and efficacy of eubiotics and preventing any harmful effects on animal health or the environment. Compliance with these regulations can be a complex and time-consuming process, which can increase the cost of production and limit market growth.

Get Free Sample Report and Related Graphs & Charts @ https://www.emergenresearch.com/request-sample/577

Despite these challenges, there are several growth factors driving the eubiotics market. One of the key growth factors is the increasing focus on animal nutrition and health. The livestock industry is becoming more aware of the importance of animal health and nutrition for ensuring optimal productivity and profitability. Eubiotics are increasingly being recognized as an effective and safe way to improve animal health and performance, which is driving market growth.

Moreover, the growing demand for organic meat and dairy products is expected to drive the eubiotics market. Consumers are becoming more conscious about the quality and safety of the food they consume, and there is a growing preference for organic and natural products. Eubiotics are considered a natural and safe way to improve animal health and performance, making them a preferred choice for organic livestock farming.

The eubiotics market is an emerging market that is rapidly gaining attention due to its various benefits. The market is driven by various factors such as the increasing demand for meat and animal-based products, growing focus on animal health and nutrition, and the rising awareness among consumers about the health benefits of eubiotics. However, the market also faces some restraints such as stringent regulations and compliance issues. With the growing demand for organic and natural products, the eubiotics market is expected to grow significantly in the coming years.

Major Companies and Competitive Landscape:

The competitive landscape for the Eubiotics Market is highly fragmented with the presence of several international and regional players. The market players are focusing on expanding their product portfolio and enhancing their production capacities to cater to the growing demand for eubiotics in the livestock industry.

The key players in the eubiotics market include BASF SE, Novus International, Lallemand Inc., Cargill Inc., Koninklijke DSM NV, Kemin Industries, Lesaffre Group, Behn Mayer Group, Yara International ASA, and DuPont.

These players are adopting various strategies such as mergers and acquisitions, partnerships, collaborations, and new product launches to maintain their position in the market. For instance, in 2021, DSM Nutritional Products AG launched its DelvoX-L range of eubiotics for poultry and swine, which is expected to enhance the gut health of animals and improve their overall performance.

Additionally, the players are investing heavily in research and development activities to develop innovative and effective eubiotics that can cater to the changing requirements of the livestock industry. For instance, in 2021, Chr. Hansen Holding A/S invested in a new fermentation facility in Denmark to expand its production capacity for eubiotics.

Furthermore, the players are also focusing on expanding their geographical presence by entering into new markets and establishing partnerships with local players. For instance, in 2020, Kemin Industries entered into a partnership with CRVAB Bio-technology Co. Ltd. to distribute its eubiotics in China.

Looking for Discount on This Research report @ https://www.emergenresearch.com/request-discount/577

Segmentation Insights for Eubiotics Market

The eubiotics market can be analyzed based on various factors, including product outlook, form outlook, application outlook, end-use outlook, and regional outlook. In terms of product outlook, the market is segmented into probiotics, prebiotics, organic acids, essential oils, and exogenous enzymes. According to research, the global eubiotics market revenue for the period 2018-2028 is expected to be in billions of USD.

Based on the form outlook, the market is segmented into solid and liquid forms. The increasing demand for liquid eubiotics, which are easy to mix with feed and water, is driving the growth of this segment. Moreover, the higher bioavailability of liquid eubiotics as compared to solid eubiotics is also contributing to the growth of this segment.

In terms of application outlook, the market is segmented into gut health, immunity, yield, and production. The gut health segment is expected to dominate the market owing to the increasing prevalence of gut-related diseases in livestock animals. Furthermore, the immunity segment is also expected to witness significant growth due to the growing demand for natural and safe alternatives to antibiotics.

Based on end-use outlook, the market is segmented into poultry, swine, ruminant, and aquaculture. The poultry segment is expected to dominate the market owing to the increasing demand for poultry products and the rising prevalence of poultry diseases. Moreover, the aquaculture segment is also expected to witness significant growth due to the growing demand for seafood and the increasing adoption of eubiotics in aquaculture.

Geographically, the eubiotics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific region is expected to dominate the market owing to the growing demand for animal protein, increasing awareness about the benefits of eubiotics, and the rising prevalence of livestock diseases in the region.

Browse Summary of the Eubiotics Market Analysis Report@ https://www.emergenresearch.com/industry-report/eubiotics-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.